Target intelligence / Profile preview

FCF1 pseudogene 3 (FCF1P3)

Target
FCF1P3
Molecular classification
Other (Pseudogene)
01

Overview

FCF1 pseudogene 3 (FCF1P3) is classified as a pseudogene in the human genome, with the NCBI Gene accession 100128733 and Ensembl ID ENSG00000239997[1][3][9]. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but do not encode functional proteins[10]. FCF1P3 resides on chromosome 3 (3q13.12) and is considered a processed pseudogene related to the FCF1 gene, which encodes a component of the small subunit (SSU) processome involved in ribosome biogenesis[3][1][9]. However, FCF1P3 itself does not produce a functional protein, and there are no reports of its involvement in any biological pathway, disease, or as a target of any drug. There is no evidence that FCF1P3 serves as a biomarker, therapeutic target, or has any established clinical relevance. Key points supporting this assessment: - FCF1P3 is specifically listed as a pseudogene, with no indication of functional protein product or disease association[1][3][9]. - It is unrelated to common therapeutic target classes such as receptors, enzymes, ion channels, or transporters. - There is no evidence in major databases or literature of biological activity, biomarker status, or drug interaction relevant to FCF1P3. - Confusion with FCF1 (functional gene) or other pseudogenes is possible, but FCF1P3 is specifically annotated as non-coding and nonfunctional[1][3][9][10].

Other names
FCF1 small subunit processome component homolog pseudogene 3FCF1P3

Beyond the preview

Go deeper on FCF1 pseudogene 3 (FCF1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FCF1 pseudogene 3 (FCF1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call